Commonwealth Equity Services, LLC P Lx Pharma Inc. Transaction History

Commonwealth Equity Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.52 - $3.08 $980 - $5,805	1,885 Added 3.9%	50,261 $32,000
Q2 2022 Jul 19, 2022	SELL	$1.9 - $4.18 $4,385 - $9,647	-2,308 Reduced 4.55%	48,376 $117,000
Q1 2022 May 04, 2022	BUY	$3.54 - $8.3 $47,655 - $111,734	13,462 Added 36.17%	50,684 $204,000
Q4 2021 Jan 31, 2022	BUY	$7.69 - $19.66 $57,067 - $145,896	7,421 Added 24.9%	37,222 $298,000
Q3 2021 Oct 29, 2021	BUY	$12.22 - $21.28 $156,147 - $271,915	12,778 Added 75.06%	29,801 $575,000
Q2 2021 Aug 11, 2021	BUY	$9.0 - $15.94 $45,261 - $80,162	5,029 Added 41.93%	17,023 $234,000
Q1 2021 May 04, 2021	BUY	$5.24 - $10.14 $62,848 - $121,619	11,994 New	11,994 $108,000

61.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.